S296-3669 Screening compound: 5-[(5-chloro-2-fluorophenyl)methyl]-2-(2-phenylethyl)-octahydropyrrolo[3,4-c]pyrrole-1,3-dione

S296-3669 Screening compound: 5-[(5-chloro-2-fluorophenyl)methyl]-2-(2-phenylethyl)-octahydropyrrolo[3,4-c]pyrrole-1,3-dione
S296-3669 Screening compound: 5-[(5-chloro-2-fluorophenyl)methyl]-2-(2-phenylethyl)-octahydropyrrolo[3,4-c]pyrrole-1,3-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound S296-3669
5-[(5-chloro-2-fluorophenyl)methyl]-2-(2-phenylethyl)-octahydropyrrolo[3,4-c]pyrrole-1,3-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S296-3669

Molecular Formula

C21H20ClFN2O2 (C21 H20 ClFN2 O2)

Compound Name

5-[(5-chloro-2-fluorophenyl)methyl]-2-(2-phenylethyl)-octahydropyrrolo[3,4-c]pyrrole-1,3-dione

IUPAC name

(3aR6aS)-5-[(5-chloro-2-fluorophenyl)methyl]-2-(2-phenylethyl)-octahydropyrrolo[34-c]pyrrole-13-dione

SMILES

O=C([C@H]1[C@@H]2CN(Cc(cc(cc3)Cl)c3F)C1)N(CCc1ccccc1)C2=O

InChI

InChI=1S/C21H20ClFN2O2/c22-16-6-7-19(23)15(10-16)11-24-12-17-18(13-24)21(27)25(20(17)26)9-8-14-4-2-1-3-5-14/h1-7,10,17-18H,8-9,11-13H2/t17-,18+

InChI Key

YIFPQURSFVFKNK-HDICACEKSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

386.85

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.264

Distribution Coefficient, logD

2.594

Water Solubility, LogSw

-3.49

Polar Surface Area

33.435

Acid Dissociation Constant (pKa)

18.67

Base Dissociation Constant (pKb)

7.97

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

33.30

S296-3669 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

CNS MPO Library (28609 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Nervous system
  • Nervous system
  • Cancer
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • GPCR
  • Ion Channels
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S296-3669 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S296-3669?
Check Price and Availability of S296-3669, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S296-3669 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S296-3669
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S296-3669
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S296-3669 available by request